Joseph M. Ortiz MD
Consultant in Ophthalmology, Abington Memorial Hospital, Abington, PennsylvaniaJoseph M. Ortiz, MD, is a graduate of Swarthmore College and earned his medical degree from New York Medical College. He did one year of anatomical pathology at Yale-New Haven Hospital which was followed by a NIH fellowship in ocular pathology at the Scheie Eye Institute-University of Pennsylvania. Dr. Ortiz completed his residency in Ophthalmology at the Scheie Eye Institute. This was followed by a glaucoma fellowship at Addenbrooke's Hospital in Cambridge, England. He completed a concurrent fellowship in ocular immune disease at Moorfields Hospital in London.
Dr. Ortiz was formerly associate professor of ophthalmology and head of the glaucoma division and associate resident program director at Drexel University in Philadelphia. Previously, he held a similar position at Cooper Hospital-UMDNJ in Camden, NJ.
He is a diplomate of the American Board of Ophthalmology and a fellow of the American Board of Ophthalmology, the Royal College of Ophthalmologists (UK) and the College of Physicians of Philadelphia. He is a member of the American Glaucoma Society, Association for Research in Vision and Ophthalmology, the American Association of Ophthalmic Oncologists and Pathologists and the American Medical Association.
Disclosures
Joseph M. Ortiz, MD, has no financial arrangement or affiliation with a corporate organization or a manufacturer of a product discussed in this supplement.
Recent Contributions to PracticeUpdate:
- Effect of Early Postoperative Aqueous Suppression Therapy on Ahmed Tube Shunt Implantation Outcomes in Patients With Refractory Glaucoma
- Short-Term Effects of 1% Tropicamide Drop Use on Pupillary Diameter and IOP Change in Patients With Pseudoexfoliation Material
- Patterns and Disparities in Recorded Gonioscopy During Initial Glaucoma Evaluations in the US
- Efficacy of Cataract Surgery With iStent Inject Insertion vs Cataract Surgery Alone
- Outcomes of Graft-Free Tube Shunt Implantation and Risk Factors for Tube Exposures in Patients With Glaucoma
- Outcomes of Netarsudil/Latanoprost vs Bimatoprost/Timolol Therapy in Patients With Open-Angle Glaucoma or Ocular Hypertension
- Evaluating Primary Treatment Outcomes in Individuals Presenting With Advanced Glaucoma
- Risk of Glaucoma Development in Patients With Central Serous Chorioretinopathy
- Incidence and Treatment of IOP Elevation Associated With Local Steroid Therapies for Retinal Diseases
- Utility of Central Visual Field Testing in the Management of Patients With Early Glaucoma